Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of ICU-Hospitalized COVID-19 Patients

Table 1

Demographics and baseline characteristics of patients.

		Overall (N = 391)
		General data			N		%
Age		≤60 y			156		39.9
		>60 y			235		60.1
Sex		Male			224		57.3
		Female			167		42.7
O2Sat, baseline		O2 < 88%			316		80.8
		92% > O2 ≥ 88%			59		15.1
		O2 ≥ 92%			16		4.1
Comorbidities		HTN			162		41.4
		DM			156		39.9
		IHD			82		21
		CKD			81		20.7
		COPD			54		13.8
		CVA			40		10.2
		DLP			38		9.7
		ESRD			24		6.1
		Brain hemorrhage			23		5.9
		Cancer			12		3.1
		Hypothyroidism			9		2.3
		Seizure			9		2.3
		IPF			7		1.8
		Cirrhosis			5		1.3
		Trauma			3		0.8
		Parkinson			3		0.8
		Rheumatoid arteritis			2		0.5
		Sickle cell			2		0.5
		MS			2		0.5
		LAM			1		0.3
Imaging result (score of lung involvement) at baseline		Mild (0–8)			81		20.7
		Moderate (9–16)			168		43
		Severe (17–25)			142		36.3
Type of CT involvement		Consolidation			133		34
		GGO			100		25.6
		Mix			44		11.25
		Reticular + Fibrosis			35		8.95
		PE			33		8.40
		Nodular			23		5.90
		Crazy paving			23		5.90
Laboratory findings		CRP		Negative	78		19.9
				+	77		19.7
				++	131		33.5
				+++	105		26.9
		WBC		WBC<4000	44		11.26
				WBC: 4000–10000	219		56.01
				WBC>10000	128		32.73
					Mean ± SD
		WBC			9.27 ± 5.58
		ESR			46.05 ± 28.81
		CPK			396.19 ± 678.29
		LDH			711.39 ± 414.09
		NLR			10.39 ± 8.66
		RBC			4.82 ± 0.78
		AST			71.61 ± 136.86
		ALT			63.96 ± 128.31
		ALP			215.08 ± 121.98
		PLT			203.44 ± 91.81
		Cr			1.76 ± 1.89
		BUN			60.98 ± 51.89

N: number; SD: standard deviation; DM: diabetes mellitus; HTN: hypertension; IHD: ischemic heart disease; DLP: dyslipidemia; COPD: chronic obstructive pulmonary disease; CVA: cerebral vascular accident; ESRD: end stage renal disease; IPF: idiopathic pulmonary fibrosis; MS: multiple sclerosis; LAM: lymphangioleiomyomatosis; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; CPK: creatine phosphokinase; LDH: lactate dehydrogenase; WBC: white blood cells; NLR: neutrophil-lymphocyte ratio; AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase; O₂Sat: oxygen saturation; Cons: considerations; GGO: ground-glass opacification; PE: pleural effusion; y: year.